Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 16, 2017
Boehringer Ingelheim and MiNA have signed a collaboration and licensing agreement focused on the development of novel compounds to treat fibrotic liver diseases.
read more
Sarepta Therapeutics has entered into a long-term strategic manufacturing partnership with Brammer Bio.
read more
Nippon Express has obtained Good Distribution Practice certification, effective Monday, March 29, 2021, for its Shanghai Pudong Airport CFS.
read more
Biofrontera has entered into an agreement to acquire all shares in Cutanea Life Sciences through its subsidiary Biofrontera Newderm LLC as the acquirer, with Maruho Co., Ltd., Japan as the seller.
read more
Codexis and Nestlé Health Science have signed an agreement to advance a lead candidate discovered through a SCA into preclinical development and early clinical studies.
read more
Catalent announced a collaboration with Ennaid Therapeutics to develop an oral, antiviral treatment targeted at COVID-19.
read more
Monday, February 01, 2021
PerkinElmer announced the addition of new assay kits to help further GPCR (G Protein-Coupled Receptor) therapeutic discovery.
read more
Tuesday, November 03, 2015
Catalent has announced that Dr. Donald E. Morel will be added to its Board of Directors, effective the next time the Board convenes, increasing the size of the Board to ten members.
read more
Wednesday, April 06, 2016
The U.S. Food and Drug Administration has approved Inflectra (infliximab-dyyb) for multiple indications. Inflectra is administered by intravenous infusion. This is the second biosimilar approved by the FDA.
read more
Envigo has announced that its Research Models and Services facility in Hyderabad, India has been granted full accreditation by the AAALAC International Council.
read more
PerkinElmer has acquired Shanghai Spectrum Instruments.
read more
Wednesday, December 28, 2016
Ascendance Biotechnology has announced the execution of an agreement with GE Healthcare providing Ascendance a right to manufacture, market and sell the GE Healthcare Cytiva® brand of human stem cell-derived heart muscle cells (“cardiomyocytes”) used...
read more
Wednesday, November 01, 2017
Moderna Therapeutics announced a new license and collaboration with AstraZeneca to co-develop and co-commercialize an mRNA therapeutic encoding for Relaxin.
read more
Wednesday, September 02, 2020
Stevanato and Nelson Laboratories have signed a partnership agreement that will provide Extractables and Leachables testing at SG US Technology Excellence Center in Boston.
read more
Integrated DNA Technologies (IDT), a Danaher company, announced the expansion of its manufacturing footprint in Coralville, Iowa. The investment delivers a more than threefold increase in synthesis capacity, enabling faster, more scalable production ...
read more